ADAM17 and precursor B-cell acute lymphoblastic leukemia: Furthermore, receiver operating characteristic curves analyses confirmed that these proteins could effectively identify individuals with B-ALL from those without B-ALL, indicating that ADAM17 and ATG3 might be potential diagnostic biomarkers and therapeutic targets for B-ALL.